Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Teva
US Army
Healthtrust
Cantor Fitzgerald
US Department of Justice
Boehringer Ingelheim
Federal Trade Commission
Cerilliant
Johnson and Johnson

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,427,798

« Back to Dashboard

Summary for Patent: 5,427,798
Title: Controlled sustained release tablets containing bupropion
Abstract:A controlled sustained release tablet having at least one year shelf life and containing bupropion hydrochloride, hydroxypropyl methylcellulose and cysteine hydrochloride or glycine hydrochloride with the tablet having a surface area to volume ratio to effectively control bupropion hydrochloride release in the body.
Inventor(s): Ludwig; Jennie Sue G. (Greenville, NC), Bass, Jr.; William L. (Farmville, NC), Sutton, Jr.; Joel E. (Greenville, NC)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:08/105,447
Patent Claim Types:
see list of patent claims
Compound; Dosage form;

Drugs Protected by US Patent 5,427,798

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,427,798

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9217295Aug 14, 1992

International Patents Family Members for US Patent 5,427,798

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 161422 ➤ Try a Free Trial
Australia 4725893 ➤ Try a Free Trial
Australia 677595 ➤ Try a Free Trial
Canada 2142320 ➤ Try a Free Trial
Cyprus 2143 ➤ Try a Free Trial
Germany 69316015 ➤ Try a Free Trial
European Patent Office 0656775 ➤ Try a Free Trial CR 2000 00018 Denmark ➤ Try a Free Trial
European Patent Office 0656775 ➤ Try a Free Trial 28/2000 Austria ➤ Try a Free Trial
Spain 2111168 ➤ Try a Free Trial
United Kingdom 9217295 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Express Scripts
Citi
Dow
Boehringer Ingelheim
Accenture
Colorcon
UBS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot